Free Trial

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive logo
$78.43 +1.45 (+1.88%)
Closing price 10/14/2025 03:58 PM Eastern
Extended Trading
$78.28 -0.15 (-0.18%)
As of 04:35 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Colgate-Palmolive - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Sell
1
Hold
5
Buy
8

Based on 14 Wall Street analysts who have issued ratings for Colgate-Palmolive in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 14 analysts, 1 has given a sell rating, 5 have given a hold rating, and 8 have given a buy rating for CL.

Consensus Price Target

$92.21
17.58% Upside
According to the 14 analysts' twelve-month price targets for Colgate-Palmolive, the average price target is $92.21. The highest price target for CL is $105.00, while the lowest price target for CL is $80.00. The average price target represents a forecasted upside of 17.58% from the current price of $78.43.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for CL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Colgate-Palmolive and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CL Analyst Ratings Over Time

TypeCurrent Forecast
10/15/24 to 10/15/25
1 Month Ago
9/15/24 to 9/15/25
3 Months Ago
7/17/24 to 7/17/25
1 Year Ago
10/16/23 to 10/15/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
8 Buy rating(s)
7 Buy rating(s)
8 Buy rating(s)
13 Buy rating(s)
Hold
5 Hold rating(s)
3 Hold rating(s)
9 Hold rating(s)
8 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$92.21$98.00$101.00$106.00
Forecasted Upside17.58% Upside19.37% Upside15.72% Upside4.34% Upside
Consensus RatingModerate BuyModerate BuyHoldModerate Buy

CL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Colgate-Palmolive Stock vs. The Competition

TypeColgate-PalmoliveConsumer Staples CompaniesS&P 500
Consensus Rating Score
2.50
2.14
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside17.58% Upside109.34% Upside12.88% Upside
News Sentiment Rating
Positive News

See Recent CL News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
10/10/2025Deutsche Bank Aktiengesellschaft
3 of 5 stars
 Set Target$86.00+10.51%
10/10/2025JPMorgan Chase & Co.
2 of 5 stars
Andrea Teixeira
Andrea Teixeira
Not Rated
Lower TargetOverweight$95.00 ➝ $88.00+12.97%
10/8/2025UBS Group
4 of 5 stars
Peter Grom
Not Rated
Lower TargetBuy$99.00 ➝ $92.00+17.31%
10/8/2025Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetBuy$98.00 ➝ $88.00+12.48%
10/8/2025Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Reiterated RatingHold (C)
10/3/2025Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$84.00+7.28%
10/2/2025The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetBuy$106.00 ➝ $91.00+15.92%
10/1/2025Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetEqual Weight$87.00 ➝ $82.00+2.50%
9/25/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetUnderweight$83.00 ➝ $80.00-1.26%
8/4/2025Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetBuy$108.00 ➝ $105.00+25.93%
8/4/2025Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetOverweight$104.00 ➝ $96.00+15.10%
2/3/2025Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetHold$95.00 ➝ $93.00+7.86%
2/3/2025Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$110.00 ➝ $105.00+21.20%
1/29/2025Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSector Perform$101.00 ➝ $101.00+12.10%
1/8/2025TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetBuy$110.00 ➝ $100.00+14.53%
8/1/2024Redburn Atlantic
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold
7/30/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetMarket Perform$100.00 ➝ $103.00+3.00%
7/26/2024Hsbc Global Res
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-BuyHold
7/26/2024HSBC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Reiterated RatingBuyHold
7/24/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 DowngradeBuyHold$103.00 ➝ $95.00-1.61%
7/18/2024Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetOutperform$100.00 ➝ $106.00+6.91%
6/24/2024BNP Paribas
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOutperform$109.00+12.06%
5/15/2024Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$97.00 ➝ $107.00+13.01%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 04:53 AM ET.


Should I Buy Colgate-Palmolive Stock? CL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, October 14, 2025. Please send any questions or comments about these Colgate-Palmolive pros and cons to contact@marketbeat.com.

Colgate-Palmolive
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Colgate-Palmolive:

  • The current stock price is around $78, which may present a buying opportunity for investors looking for value.
  • Colgate-Palmolive reported a strong quarterly earnings result, with earnings per share exceeding expectations, indicating solid financial performance.
  • The company has a high return on equity, suggesting effective management and profitability, which can be attractive to investors.
  • Colgate-Palmolive has a consistent dividend payout, with a recent quarterly dividend of $0.52, reflecting its commitment to returning value to shareholders.
  • Institutional investors hold a significant portion of the company's stock, indicating confidence in its long-term prospects.

Colgate-Palmolive
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Colgate-Palmolive for these reasons:

  • The stock has a relatively high price-to-earnings ratio, which may suggest that it is overvalued compared to its earnings potential.
  • Colgate-Palmolive has a high debt-to-equity ratio, indicating that the company relies heavily on debt financing, which can be risky in volatile markets.
  • Recent price target adjustments by analysts, including a downgrade from $104 to $96, may signal concerns about future growth prospects.
  • The stock has experienced a decline from its fifty-two week high, which could indicate a downward trend that investors should be cautious about.
  • Market analysts have mixed ratings on the stock, with some suggesting a hold or sell, which may reflect uncertainty about its future performance.

CL Forecast - Frequently Asked Questions

According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Colgate-Palmolive is $92.21, with a high forecast of $105.00 and a low forecast of $80.00.

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last twelve months. There is currently 1 sell rating, 5 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CL shares.

According to analysts, Colgate-Palmolive's stock has a predicted upside of 17.58% based on their 12-month stock forecasts.

Analysts like Colgate-Palmolive more than other "consumer staples" companies. The consensus rating for Colgate-Palmolive is Moderate Buy while the average consensus rating for "consumer staples" companies is Hold. Learn more on how CL compares to other companies.


This page (NYSE:CL) was last updated on 10/15/2025 by MarketBeat.com Staff
From Our Partners